icd10free.comPowered by Curo

ICD-10 Coding for Empagliflozin(E11.9, E10.9, E11.22)

Save

Comprehensive guide on ICD-10 coding for empagliflozin, including documentation requirements and common pitfalls.

Also known as:
Jardiance
Related ICD-10 Code Ranges

Complete code families applicable to Empagliflozin

E00-E89Primary Range

Endocrine, nutritional and metabolic diseases

→
Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
E11.9Type 2 diabetes mellitus without complications
I50.23Acute on chronic systolic (congestive) heart failure
E11.22Type 2 diabetes mellitus with diabetic chronic kidney disease
Primary ICD-10-CM Codes
Type 2 diabetes mellitus without complications
E11.9Billable
Differential Codes

Alternative codes to consider when ruling out similar conditions

Type 1 diabetes mellitus without complicationsE10.9
Acute on chronic diastolic (congestive) heart failureI50.33
Chronic kidney disease, unspecifiedN18.9

Documentation & Coding Risks

Avoid these common issues when documenting Empagliflozin.

Using E11.9 without specifying diabetes type.

Impact

Clinical: May lead to inappropriate treatment plans., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.

Mitigation

Always specify Type 2 Diabetes Mellitus when coding., Use E11.9 only when no complications are present.

Omitting Z79.84 when empagliflozin is prescribed.

Impact

Reimbursement: May result in denied claims or reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate representation of patient medication use.

Mitigation

Always include Z79.84 with E11.9 when empagliflozin is used.

Medication Coding

Impact

Failure to code long-term medication use.

Mitigation

Implement regular audits of medication coding practices.

Frequently Asked Questions

Related condition guides

Documentation requirements, coding pitfalls and FAQs for conditions coded with E11.9.